Skip to main content

Table 3 Differences in clinical outcomes between Intervention group and Control Group (1)

From: Assessing the efficacy of a modified assertive community-based treatment programme in a developing country

Item Intervention Control    
   Mean (±SD) n Mean (±SD) n t-value df p
Baseline (mean) PANNS-P total 32.29 (±5.62) 31 31.43 (±5.21) 21 0.56 50 0.58
  PANNS-N total 25.06 (±6.82) 31 20.00 (±6.80) 21 2.63 50 0.01*
  PANNS-G total 48.16 (±9.21) 31 45.67 (±6.37) 21 1.08 50 0.29
Intervention (n = 31)
Control (n = 21)
PANNS-Total 105.52 (±18.58) 31 97.10 (±15.20) 21 1.72 50 0.09
  SOFAS 34.29 (±3.58) 31 36.29 (±6.37) 21 -0.89 50 0.38
  CDSS 2.35 (±18.58) 31 1.05 (±1.47) 21 1.58 50 0.12
  ESRS-questionnaire 3.16 (±2.48) 31 2.43 (±2.40) 21 1.06 50 0.29
  ESRS-parkinsonism 8.84 (±7.28) 31 8.81 (±5.55) 21 0.02 50 0.99
  ESRS-dystonia 0.00 (±0.00) 31 0.10 (±0.44) 21 -1.22 50 0.23
  ESRS-dyskinetic 0.61 (±2.38) 31 0.57 (±2.62) 21 0.06 50 0.95
Endpoint PANNS-P total 12.52 (±6.0) 29 19.38 (±8.8) 21 -3.28 48 0.00*
  PANNS-N total 16.55 (±6.1) 29 19.33 (±4.6) 21 -1.76 48 0.09
  PANNS-G total 28.45 (±8.2) 29 34.81 (±9.1) 21 -2.58 48 0.01*
  PANNS-Total 57.52 (±17.4) 29 73.52 (±19.2) 21 -3.07 48 0.00*
Intervention ( n = 29)
Control (n = 21)
SOFAS 61.97 (±9.1) 29 54.90 (±10.8) 21 2.50 48 0.02*
  CDSS total 0.69 (±1.4) 29 0.81 (±3.3) 21   48 0.86
  ESRS-questionnaire 1.90 (±1.23) 29 1.90 (±1.51) 21 -0.02 48 0.98
  ESRS-parkinsonism 9.03 (±8.20) 29 0.48 (±8.07) 21 0.48 48 0.63
  ESRS-dystonia 0.00 (±0.00) 29 0.00 (±0.00) 21   48  
  ESRS-dyskinetic 0.55 (±1.24) 29 0.57 (±1.57) 21 -0.05 48 0.96
  1. *Significance at p < 0.05